Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 530

1.

Clinical Management of Pain in Rodents.

Foley PL, Kendall LV, Turner PV.

Comp Med. 2019 Dec 10. doi: 10.30802/AALAS-CM-19-000048. [Epub ahead of print]

PMID:
31822323
2.

Maintenance of clinical response and consistent safety profile with up to three years of continuous treatment with guselkumab: results from the VOYAGE 1 and VOYAGE 2 trials.

Reich K, Griffiths CEM, Gordon KB, Papp KA, Song M, Randazzo B, Li S, Shen YK, Han C, Kimball AB, Armstrong AW, Foley P, Blauvelt A.

J Am Acad Dermatol. 2019 Dec 3. pii: S0190-9622(19)33132-9. doi: 10.1016/j.jaad.2019.11.040. [Epub ahead of print]

PMID:
31809827
3.

Two Stories about Diet and Diabetes in Europe.

Foley PJT, Gunson JTS, Baumann SL.

Nurs Sci Q. 2020 Jan;33(1):85-90. doi: 10.1177/0894318419881797.

PMID:
31795891
4.

Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrative.

Rademaker M, Agnew K, Andrews M, Baker C, Foley P, Gebauer K, Gupta M, Rubel DM, Somerville C, Sullivan J, Wong LC.

Australas J Dermatol. 2019 Sep 16. doi: 10.1111/ajd.13141. [Epub ahead of print] Review.

PMID:
31529493
5.

Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study.

Deleuran M, Thaçi D, Beck LA, de Bruin-Weller M, Blauvelt A, Forman S, Bissonnette R, Reich K, Soong W, Hussain I, Foley P, Hide M, Bouaziz JD, Gelfand JM, Sher L, Schuttelaar MLA, Wang C, Chen Z, Akinlade B, Gadkari A, Eckert L, Davis JD, Rajadhyaksha M, Staudinger H, Graham NMH, Pirozzi G, Ardeleanu M.

J Am Acad Dermatol. 2019 Jul 30. pii: S0190-9622(19)32465-X. doi: 10.1016/j.jaad.2019.07.074. [Epub ahead of print]

6.

Atopic dermatitis in adults: An Australian management consensus.

Smith S, Baker C, Gebauer K, Rubel D, Frankum B, Soyer HP, Weightman W, Sladden M, Rawlin M, Headley AP, Somerville C, Beuth J, Logan N, Mewton E, Foley P.

Australas J Dermatol. 2019 Aug 1. doi: 10.1111/ajd.13124. [Epub ahead of print]

PMID:
31372984
7.

Flare of palmoplantar psoriasis with ustekinumab.

Daniel BS, Baker C, Foley P.

Australas J Dermatol. 2019 Aug 1. doi: 10.1111/ajd.13122. [Epub ahead of print] No abstract available.

PMID:
31372980
8.

Everything You Need to Know About Satisfying IACUC Protocol Requirements.

Mohan S, Foley PL.

ILAR J. 2019 Jul 30. pii: ilz010. doi: 10.1093/ilar/ilz010. [Epub ahead of print]

PMID:
31361817
9.

The origins and early history of neurochemistry and its societies.

Boullerne AI, Foley P, Turner AJ, Johnston GAR, Beart PM.

J Neurochem. 2019 Jul 29. doi: 10.1111/jnc.14839. [Epub ahead of print] Review.

PMID:
31357242
10.

Effects of stylet-in versus stylet-out collection of cerebrospinal fluid from the cisterna magna on contamination of samples, sample quality, and collection time.

Shamir SK, Hagen CRM, Foley PM, Gilroy CV, Yu J, Amsellem PM.

Am J Vet Res. 2019 Aug;80(8):787-791. doi: 10.2460/ajvr.80.8.787.

PMID:
31339768
11.

His bundle pacing, learning curve, procedure characteristics, safety, and feasibility: Insights from a large international observational study.

Keene D, Arnold AD, Jastrzębski M, Burri H, Zweibel S, Crespo E, Chandrasekaran B, Bassi S, Joghetaei N, Swift M, Moskal P, Francis DP, Foley P, Shun-Shin MJ, Whinnett ZI.

J Cardiovasc Electrophysiol. 2019 Oct;30(10):1984-1993. doi: 10.1111/jce.14064. Epub 2019 Aug 2.

PMID:
31310403
12.

Guselkumab improves work productivity in patients with moderate-to-severe psoriasis with or without depression and anxiety: results from the VOYAGE 2 comparator study versus adalimumab.

Reich K, Foley P, Han C, McElligott S, Muser E, Li N, Armstrong AW.

J Dermatolog Treat. 2019 Jul 15:1-7. doi: 10.1080/09546634.2019.1628172. [Epub ahead of print]

PMID:
31305186
13.

The MJA in 2019: a long tradition and increasingly high and broad impact.

Foley PB, Gee CE, Talley Ac NJ.

Med J Aust. 2019 Aug;211(3):101-102. doi: 10.5694/mja2.50273. Epub 2019 Jul 14. No abstract available.

PMID:
31304597
14.

Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 Study.

Gordon KB, Armstrong AW, Foley P, Song M, Shen YK, Li S, Muñoz-Elías EJ, Branigan P, Liu X, Reich K.

J Invest Dermatol. 2019 Dec;139(12):2437-2446.e1. doi: 10.1016/j.jid.2019.05.016. Epub 2019 Jun 15.

PMID:
31207232
15.

Coexisting median canaliform nail dystrophy and habit-tic deformity in a patient with atopic dermatitis.

Wang C, Lee S, Howard A, Foley P.

Australas J Dermatol. 2019 Jun 3. doi: 10.1111/ajd.13084. [Epub ahead of print] No abstract available.

PMID:
31155700
16.

American Board of Orthodontics: Update on the new scenario-based clinical examination.

Tadlock LP, Barone N, Pangrazio-Kulbersh V, Sabott DG, Foley PF, Trulove TS, Park JH, Hernandez-Orsini R, Chung CH.

Am J Orthod Dentofacial Orthop. 2019 Jun;155(6):765-766. doi: 10.1016/j.ajodo.2019.04.004.

PMID:
31153496
17.

Initial assessment of the early arthritis for psoriatic patients diagnostic questionnaire in dermatology clinics in Australia, Korea and China.

Jo SJ, Foley P, Oakley SP, Zhang J, Zheng M, Shin K, McGonagle D, Gisondi P, Tinazzi I, Butcher BE, Handel M.

Int J Rheum Dis. 2019 Aug;22(8):1512-1520. doi: 10.1111/1756-185X.13604. Epub 2019 May 22.

PMID:
31115158
18.

A Digital Behavioral Weight Gain Prevention Intervention in Primary Care Practice: Cost and Cost-Effectiveness Analysis.

Krishnan A, Finkelstein EA, Levine E, Foley P, Askew S, Steinberg D, Bennett GG.

J Med Internet Res. 2019 May 17;21(5):e12201. doi: 10.2196/12201.

19.

A case of widespread molluscum contagiosum caused by baricitinib, a Janus kinase inhibitor.

Wong GN, Lee S, Foley P.

Australas J Dermatol. 2019 Nov;60(4):e334-e335. doi: 10.1111/ajd.13059. Epub 2019 Apr 22. No abstract available.

PMID:
31012089
20.

Trends in inferior vena cava filter placement and retrieval at a tertiary care institution.

Belkin N, Jackson BM, Foley PJ, Damrauer SM, Kalapatapu V, Golden MA, Fairman RM, Wang GJ.

J Vasc Surg Venous Lymphat Disord. 2019 May;7(3):405-412. doi: 10.1016/j.jvsv.2018.11.007. Epub 2019 Mar 15.

PMID:
30885629
21.

Renal function and the long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation.

Leyva F, Zegard A, Taylor R, Foley PWX, Umar F, Patel K, Panting J, Ferro CJ, Chalil S, Marshall H, Qiu T.

Pacing Clin Electrophysiol. 2019 Jun;42(6):595-602. doi: 10.1111/pace.13659. Epub 2019 Apr 3.

22.

His Bundle Pacing: A New Strategy for Physiological Ventricular Activation.

Lewis AJM, Foley P, Whinnett Z, Keene D, Chandrasekaran B.

J Am Heart Assoc. 2019 Mar 19;8(6):e010972. doi: 10.1161/JAHA.118.010972. No abstract available. Erratum in: J Am Heart Assoc. 2019 Jun 4;8(11):e002310.

23.

Dopamine in psychiatry: a historical perspective.

Foley PB.

J Neural Transm (Vienna). 2019 Apr;126(4):473-479. doi: 10.1007/s00702-019-01987-0. Epub 2019 Feb 13. Review.

PMID:
30758785
24.

Solar urticaria - An Australian case series of 83 patients.

Photiou L, Foley P, Ross G.

Australas J Dermatol. 2019 May;60(2):110-117. doi: 10.1111/ajd.12975. Epub 2018 Dec 25. Review.

PMID:
30585308
25.

Life threatening polyserositis post oesophagectomy.

Alaee S, Foley PWX, Stanton AE.

Respir Med Case Rep. 2018 Nov 15;26:42-44. doi: 10.1016/j.rmcr.2018.11.006. eCollection 2019.

26.
27.

Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study.

Yosipovitch G, Foley P, Ryan C, Cather JC, Meeuwis KA, Burge R, Bleakman AP, Lin CY, Malatestinic W, Gottlieb A.

J Sex Med. 2018 Nov;15(11):1645-1652. doi: 10.1016/j.jsxm.2018.09.004.

28.

Long-Term Outcomes of Cardiac Resynchronization Therapy Using Apical Versus Nonapical Left Ventricular Pacing.

Leyva F, Zegard A, Taylor RJ, Foley PWX, Umar F, Patel K, Panting J, van Dam P, Prinzen FW, Marshall H, Qiu T.

J Am Heart Assoc. 2018 Aug 21;7(16):e008508. doi: 10.1161/JAHA.117.008508.

29.

Effectiveness of an App and Provider Counseling for Obesity Treatment in Primary Care.

Bennett GG, Steinberg D, Askew S, Levine E, Foley P, Batch BC, Svetkey LP, Bosworth HB, Puleo EM, Brewer A, DeVries A, Miranda H.

Am J Prev Med. 2018 Dec;55(6):777-786. doi: 10.1016/j.amepre.2018.07.005. Epub 2018 Oct 22.

30.

Revisiting Inbred Mouse Models to Study the Developing Brain: The Potential Role of Intestinal Microbiota.

Oriá RB, Malva JO, Foley PL, Freitas RS, Bolick DT, Guerrant RL.

Front Hum Neurosci. 2018 Sep 19;12:358. doi: 10.3389/fnhum.2018.00358. eCollection 2018. No abstract available.

31.

Length of Stay after Thoracic Endovascular Aortic Repair Depends on Indication and Acuity.

Belkin N, Jackson BM, Foley PJ, Damrauer SM, Kalapatapu V, Golden MA, Fairman RM, Kelz RR, Wang GJ.

Ann Vasc Surg. 2019 Feb;55:157-165. doi: 10.1016/j.avsg.2018.06.027. Epub 2018 Sep 11.

PMID:
30217710
32.

Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis.

Papp K, Gordon K, Thaçi D, Morita A, Gooderham M, Foley P, Girgis IG, Kundu S, Banerjee S.

N Engl J Med. 2018 Oct 4;379(14):1313-1321. doi: 10.1056/NEJMoa1806382. Epub 2018 Sep 11.

33.

Caffeine and Sprint Cycling Performance: Effects of Torque Factor and Sprint Duration.

Glaister M, Towey C, Jeffries O, Muniz-Pumares D, Foley P, McInnes G.

Int J Sports Physiol Perform. 2019 Apr 1;14(4):426-431. doi: 10.1123/ijspp.2018-0458. Epub 2019 Feb 19.

PMID:
30204516
34.

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.

Gordon KB, Strober B, Lebwohl M, Augustin M, Blauvelt A, Poulin Y, Papp KA, Sofen H, Puig L, Foley P, Ohtsuki M, Flack M, Geng Z, Gu Y, Valdes JM, Thompson EHZ, Bachelez H.

Lancet. 2018 Aug 25;392(10148):650-661. doi: 10.1016/S0140-6736(18)31713-6. Epub 2018 Aug 7.

PMID:
30097359
35.

PCR Testing of Filter Material from IVC Lids for Microbial Monitoring of Mouse Colonies.

Dubelko AR, Zuwannin M, McIntee SC, Livingston RS, Foley PL.

J Am Assoc Lab Anim Sci. 2018 Sep 1;57(5):477-482. doi: 10.30802/AALAS-JAALAS-18-000008. Epub 2018 Aug 9.

36.

Psoriasis and infection. A clinical practice narrative.

Rademaker M, Agnew K, Anagnostou N, Andrews M, Armour K, Baker C, Foley P, Gebauer K, Gupta M, Marshman G, Rubel D, Sullivan J, Wong LC.

Australas J Dermatol. 2019 May;60(2):91-98. doi: 10.1111/ajd.12895. Epub 2018 Aug 5. Review.

PMID:
30079566
37.

Building Meaningful Patient Engagement in Research: Case Study From ADVANCE Clinical Data Research Network.

Warren NT, Gaudino JA Jr, Likumahuwa-Ackman S, Dickerson K, Robbins L, Norman K, Lind J, D'Amato S, Foley P, Gold R, Bauer V, Fields SA, Cohen DJ, Clark KD, DeVoe JE.

Med Care. 2018 Oct;56 Suppl 10 Suppl 1:S58-S63. doi: 10.1097/MLR.0000000000000791.

38.

Psoriasis and cancer. An Australian/New Zealand narrative.

Rademaker M, Rubel DM, Agnew K, Andrews M, Armour KS, Baker C, Foley P, Gebauer K, Goh MS, Gupta M, Marshman G, Prince HM, Sullivan J.

Australas J Dermatol. 2019 Feb;60(1):12-18. doi: 10.1111/ajd.12889. Epub 2018 Jul 10. Review.

PMID:
29992535
39.

Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) trial.

Keene D, Arnold A, Shun-Shin MJ, Howard JP, Sohaib SA, Moore P, Tanner M, Quereshi N, Muthumala A, Chandresekeran B, Foley P, Leyva F, Adhya S, Falaschetti E, Tsang H, Vijayaraman P, Cleland JGF, Stegemann B, Francis DP, Whinnett ZI.

ESC Heart Fail. 2018 Oct;5(5):965-976. doi: 10.1002/ehf2.12315. Epub 2018 Jul 9. Review.

40.

Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study.

Zouboulis CC, Okun MM, Prens EP, Gniadecki R, Foley PA, Lynde C, Weisman J, Gu Y, Williams DA, Jemec GBE.

J Am Acad Dermatol. 2019 Jan;80(1):60-69.e2. doi: 10.1016/j.jaad.2018.05.040. Epub 2018 Jun 1.

PMID:
29860040
41.

Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical Trials.

Foley P, Gordon K, Griffiths CEM, Wasfi Y, Randazzo B, Song M, Li S, Shen YK, Blauvelt A.

JAMA Dermatol. 2018 Jun 1;154(6):676-683. doi: 10.1001/jamadermatol.2018.0793.

42.

Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy: The BRAVO Trial.

Whinnett ZI, Sohaib SMA, Mason M, Duncan E, Tanner M, Lefroy D, Al-Obaidi M, Ellery S, Leyva-Leon F, Betts T, Dayer M, Foley P, Swinburn J, Thomas M, Khiani R, Wong T, Yousef Z, Rogers D, Kalra PR, Dhileepan V, March K, Howard J, Kyriacou A, Mayet J, Kanagaratnam P, Frenneaux M, Hughes AD, Francis DP.

JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1407-1416. doi: 10.1016/j.jcmg.2018.02.014. Epub 2018 May 16.

43.

Anxiety and depression in patients with moderate-to-severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results from the Phase 3 VOYAGE 2 study.

Gordon KB, Armstrong AW, Han C, Foley P, Song M, Wasfi Y, You Y, Shen YK, Reich K.

J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1940-1949. doi: 10.1111/jdv.15012. Epub 2018 Jul 18.

PMID:
29706008
44.

Ixekizumab-treatment-emergent photosensitive cutaneous eruption.

Anthony E, Rajgopal Bala H, Goh MS, Balta S, Foley P.

Australas J Dermatol. 2018 Nov;59(4):e284-e286. doi: 10.1111/ajd.12811. Epub 2018 Mar 22. No abstract available.

PMID:
29566260
45.

The centennial lesson of encephalitis lethargica.

Lutters B, Foley P, Koehler PJ.

Neurology. 2018 Mar 20;90(12):563-567. doi: 10.1212/WNL.0000000000005176.

PMID:
29555881
46.

Comparison of Flea (Siphonaptera) Burdens on the Endangered San Joaquin Kit Fox (Vulpes macrotis mutica (Carnivora, Canidae)) Inhabiting Urban and Nonurban Environments in Central Valley, California.

Riner AJ, Rudd JL, Clifford DL, Cypher BL, Foley JE, Foley P.

J Med Entomol. 2018 Jun 28;55(4):995-1001. doi: 10.1093/jme/tjy031.

PMID:
29546382
47.

National trends in admissions, repair, and mortality for thoracic aortic aneurysm and type B dissection in the National Inpatient Sample.

Wang GJ, Jackson BM, Foley PJ, Damrauer SM, Goodney PP, Kelz RR, Wirtalla C, Fairman RM.

J Vasc Surg. 2018 Jun;67(6):1649-1658. doi: 10.1016/j.jvs.2017.09.050. Epub 2018 Mar 2.

PMID:
29506945
48.

American Board of Orthodontics: Time for change.

Chung CH, Tadlock LP, Barone N, Pangrazio-Kulbersh V, Sabott DG, Foley PF, Trulove TS, Park JH, Dugoni SA.

Am J Orthod Dentofacial Orthop. 2018 Mar;153(3):321-323. doi: 10.1016/j.ajodo.2017.12.005.

PMID:
29501098
49.

Confirmation of the Cardiac Safety of PGF Receptor Antagonist OBE022 in a First-in-Human Study in Healthy Subjects, Using Intensive ECG Assessments.

Täubel J, Lorch U, Coates S, Fernandes S, Foley P, Ferber G, Gotteland JP, Pohl O.

Clin Pharmacol Drug Dev. 2018 Nov;7(8):889-900. doi: 10.1002/cpdd.447. Epub 2018 Feb 28.

50.

Efficacy and safety of continuous every-2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase III trial (IXORA-P).

Langley RG, Papp K, Gooderham M, Zhang L, Mallinckrodt C, Agada N, Blauvelt A, Foley P, Polzer P; of the IXORA-P Investigators.

Br J Dermatol. 2018 Jun;178(6):1315-1323. doi: 10.1111/bjd.16426. Epub 2018 May 15.

PMID:
29405255

Supplemental Content

Support Center